Navigation Links
STAAR Surgical Receives Japanese Clearance for the KS-Ni Preloaded IOL Injector System
Date:6/17/2009

MONROVIA, Calif., June 17 /PRNewswire-FirstCall/ -- STAAR Surgical Company (Nasdaq: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced the approval of the KS-Ni Preloaded Silicone Intraocular Lens (IOL) injector system by Japanese regulatory authorities.

The KS-Ni Preloaded Silicone IOL Injector System allows the surgeon to deliver STAAR Japan's blue-blocker silicone IOL through an incision size of 2.6 mm as compared to the current 3.2 mm incision size. A smaller incision will likely induce less astigmatism and allows for quicker healing. The KS-Ni Preloaded System also provides for fewer steps in the delivery process of the IOL making the system more user friendly for nurses and surgeons.

"The approval of the KS-Ni Preloaded IOL Injector continues to highlight the rapid fire launch of products that leverage STAAR Japan's expertise in the area of preloaded delivery systems for foldable IOLs," said Barry G. Caldwell, President and CEO of STAAR Surgical. "During the past week STAAR has received three different product regulatory approvals in the U.S., Europe and now Japan which illustrates the results of our continuous improvement efforts by our quality and regulatory teams."

The KS-Ni Preloaded Injector System also offers benefits to the Company as there are more than one third fewer components making the system easier to assemble and less costly to manufacture. The Company is evaluating the opportunity to expand the system to other key markets.

About STAAR Surgical

STAAR Surgical is a leader in the development, manufacture and marketing of minimally invasive ophthalmic products employing proprietary technologies. STAAR's products include the Visian ICL, a tiny, flexible lens implanted to correct refractive errors, as
'/>"/>

SOURCE STAAR Surgical Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. STAAR Surgical Reports Operational Progress
2. STAAR Surgical Announces Third Quarter 2007 Earnings Release Date and Conference Call
3. STAAR Surgical to Purchase Canons Interest in Japanese Joint Venture
4. STAAR Surgical Reports Third Quarter Results
5. Barry G. Caldwell Named Chief Executive Officer of STAAR Surgical
6. STAAR Surgical to Present at the BMO Capital Markets Focus on Healthcare Conference
7. STAAR Surgical Completes $5M Debt Financing for Purchase of Japanese Joint Venture
8. STAAR Surgical to Present at the Tenth Annual Needham Growth Conference
9. STAAR Surgical Announces Fourth Quarter and Full Year 2007 Earnings Release Date and Conference Call
10. STAAR Surgicals Visian ICL Procedure Performed Live on NBCs Today show
11. STAAR Surgical Reports Fourth Quarter and Year End Results
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Dr. Robert W. Conn Named President of The Kavli Foundation 2Health News:Dr. Robert W. Conn Named President of The Kavli Foundation 3Health News:Dr. Robert W. Conn Named President of The Kavli Foundation 4Health News:Journal of American College of Surgeons finds lung transplantation should be used in older patients 2Health News:Nurse practitioners don't realize how much their prescribing is being influenced by drug marketing 2Health News:Nurse practitioners don't realize how much their prescribing is being influenced by drug marketing 3Health News:Security Health Plan Becomes First ICSI Sponsor Outside of Minnesota 2Health News:Security Health Plan Becomes First ICSI Sponsor Outside of Minnesota 3Health News:Oh Baby, Interventional Radiology Makes Childbirth Safer 2Health News:Oh Baby, Interventional Radiology Makes Childbirth Safer 3Health News:Oh Baby, Interventional Radiology Makes Childbirth Safer 4Health News:Oh Baby, Interventional Radiology Makes Childbirth Safer 5Health News:Less Invasive Interventional Treatment Can Be Recommended as First-Line Treatment for 'Silent Killer,' Abdominal Aortic Aneurysm 2Health News:Less Invasive Interventional Treatment Can Be Recommended as First-Line Treatment for 'Silent Killer,' Abdominal Aortic Aneurysm 3Health News:Less Invasive Interventional Treatment Can Be Recommended as First-Line Treatment for 'Silent Killer,' Abdominal Aortic Aneurysm 4Health News:Less Invasive Interventional Treatment Can Be Recommended as First-Line Treatment for 'Silent Killer,' Abdominal Aortic Aneurysm 5
Breaking Medicine Technology:BMP Sunstone Announces the Inclusion of Seventy Eight Drugs in China's National Insurance Catalog 2BMP Sunstone Announces the Inclusion of Seventy Eight Drugs in China's National Insurance Catalog 3Seven New Biopharmaceutical Research Companies Join PhRMA's Mission to Advance Medical Innovation 2Seven New Biopharmaceutical Research Companies Join PhRMA's Mission to Advance Medical Innovation 3Seven New Biopharmaceutical Research Companies Join PhRMA's Mission to Advance Medical Innovation 4Bayer Consumer Care Voluntarily Recalls One Lot of Combination Package of Alka-Seltzer Plus(R) Day & Night Cold Formula Liquid Gels 2EyeScience 28TM 29 Announces New Program to Improve Patient Compliance and Practice Profits 6181 1EyeScience 28TM 29 Announces New Program to Improve Patient Compliance and Practice Profits 6181 2EyeScience 28TM 29 Announces New Program to Improve Patient Compliance and Practice Profits 6181 3Nobel laureate claims the 2010 Herbert Tabor Lectureship 10699 1Nobel laureate claims the 2010 Herbert Tabor Lectureship 10699 2Trial Data on Anti Seizure Drug Might Have Been Manipulated 3A Report 61184 1Trial Data on Anti Seizure Drug Might Have Been Manipulated 3A Report 61184 2Trial Data on Anti Seizure Drug Might Have Been Manipulated 3A Report 61184 3